Herculean mistake: mephentermine associated cardiomyopathy
- PMID:32404042
- DOI: 10.1080/00913847.2020.1763146
Herculean mistake: mephentermine associated cardiomyopathy
Abstract
Case presentation: A 32-year-old professional bodybuilder presented with acute decompensated heart failure. He gave a history of anabolic androgenic steroids (AAS) use for >2 years and mephentermine use for the preceding 3 months.Management: Transthoracic echocardiography showed severe left ventricular (LV) dysfunction with a large pedunculated, mobile thrombus attached to the ventricular apex. The patient had an embolic stroke during the hospital stay, with complete neurological recovery. Following the cessation of mephentermine use, there was a steady improvement in LV function over a follow-up of 2 months. However, at 3 months, his ventricular function showed deterioration, which coincided with mephentermine reuse.Take home message: Though AAS abuse by athletes leading to such a presentation has been documented, to the best of our knowledge, a similar role of mephentermine has not been reported.
Keywords: Mephentermine; anabolic androgenic steroids; toxic cardiomyopathy; ventricular thrombus.
Similar articles
- Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG Jr.Baggish AL, et al.Circulation. 2017 May 23;135(21):1991-2002. doi: 10.1161/CIRCULATIONAHA.116.026945.Circulation. 2017.PMID:28533317Free PMC article.
- Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa KH, Almaas VM.Abdullah R, et al.Eur J Prev Cardiol. 2024 Mar 27;31(5):599-608. doi: 10.1093/eurjpc/zwad362.Eur J Prev Cardiol. 2024.PMID:37992194
- Comparison of Right Ventricle Systolic Function between Long-Term Anabolic-Androgenic Steroid User and Nonuser Bodybuilder Athletes: A Study of Two-Dimensional Speckle Tracking Echocardiography.Alizade E, Avci A, Tabakcı MM, Toprak C, Zehir R, Acar G, Kargin R, Emiroğlu MY, Akçakoyun M, Pala S.Alizade E, et al.Echocardiography. 2016 Aug;33(8):1178-85. doi: 10.1111/echo.13243. Epub 2016 May 4.Echocardiography. 2016.PMID:27144714Clinical Trial.
- Adverse effects of doping with anabolic androgenic steroids in competitive athletics, recreational sports and bodybuilding.Vorona E, Nieschlag E.Vorona E, et al.Minerva Endocrinol. 2018 Dec;43(4):476-488. doi: 10.23736/S0391-1977.18.02810-9. Epub 2018 Feb 19.Minerva Endocrinol. 2018.PMID:29463075Review.
- For the love of muscles: a bodybuilder with complicated left ventricular heart failure.De Turck L, Sarens T, Veldeman L, Vonck A.De Turck L, et al.Acta Cardiol. 2022 Nov;77(9):774-777. doi: 10.1080/00015385.2022.2080919. Epub 2022 Aug 16.Acta Cardiol. 2022.PMID:35972452Review.
Cited by
- Left ventricle pedunculated thrombi risks and outcomes: a case report and literature review.Ali AA, Sakr EE.Ali AA, et al.J Vasc Bras. 2024 Aug 9;23:e20230124. doi: 10.1590/1677-5449.202301242. eCollection 2024.J Vasc Bras. 2024.PMID:39286299Free PMC article.
- Mephentermine dependence in a young Indian adult without psychosis.Somani A.Somani A.BMJ Case Rep. 2020 Nov 2;13(11):e236924. doi: 10.1136/bcr-2020-236924.BMJ Case Rep. 2020.PMID:33139366Free PMC article.
- A Rare Case of Phentermine-Induced Nonischemic Cardiomyopathy.Damani D, Hassan M, Mahapatra S, Prakash S, Alhariri S, Bies J, Trivedi B, Edwards BP.Damani D, et al.Cureus. 2022 Nov 5;14(11):e31114. doi: 10.7759/cureus.31114. eCollection 2022 Nov.Cureus. 2022.PMID:36479398Free PMC article.
- Anabolic-Androgenic Steroid Abuse Causes Cardiac Dysfunction.Momoh R.Momoh R.Am J Mens Health. 2024 Mar-Apr;18(2):15579883241249647. doi: 10.1177/15579883241249647.Am J Mens Health. 2024.PMID:38686840Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous